Xconomy National

by in

Entry	Author	Date	Location
Targanta Cuts 75 Percent of Staff	Wade Roush	12/18/08	Boston
Targanta Preps For FDA Advisory Panel on New Antibiotic	Luke Timmerman	10/14/08	Boston
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic	Luke Timmerman	09/22/08	Boston
Targanta Antibiotic Shown Effective in Less-Frequent Dose	Luke Timmerman	09/02/08	Boston
Targanta Files for FDA Approval of Anti-MRSA Drug	Rebecca Zacks	02/11/08	Boston
Targanta Stumbles As Stock Begins Trading	Robert Buderi	10/10/07	Boston
Targanta Therapeutics Sets IPO Terms—Could Make for Nice Comeback for Firm’s CEO	Robert Buderi	09/26/07	Boston
Page 1 of 1